Latest Articles
- A world without Vioxx: To COX-2 or not to COX-2?
Are all selective COX-2 inhibitors associated with an increased risk for thromboembolic cardiovascular events? And what should we tell patients?
- Understanding valvular heart disease in patients with systemic autoimmune diseases
Specific systemic autoimmune diseases are associated with distinct valvular heart disorders. Earlier detection and management may prevent some morbidity and mortality.
- A guide to informed consent for clinician-investigators
Informed consent is a process, not a form. It is a legal and ethical safeguard to ensure that subjects enter studies voluntarily and fully informed.
- Which adults with acute diarrhea should be evaluated?
Data are scarce, but certain factors call for a more detailed evaluation.
- Hospital management of diabetes: Beyond the sliding scale
Tight glucose control has been shown to improve clinical outcomes in hospitalized patients. The challenge now is implementation.
- Tight inpatient glucose control: Why didn’t we think of this before?
Standardized algorithms to manage chronic diseases such as diabetes in the hospital should get more patients out of the hospital alive.
Drug-eluting stents: The beginning of the end of restenosis?Drug-eluting stents are here, and they are better than ordinary stents. But how much better?
- Drug-eluting stents are here—now what? Implications for clinical practice and health care costs
Many clinical and economic questions remain concerning how to apply these new stents.
- A construction worker with recent confusion, disorientation, and somnolence
What is the cause of this patient’s symptoms: the bump on the head he received at work, or his “occasional” drinking?
- Dementia with Lewy bodies: Diagnosis and clinical approach
Not all dementia is Alzheimer disease: dementia with Lewy bodies is the second most common cause, and the distinction may matter.